Erratum: 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (Updating the 2007 Guideline): A report of the American college of cardiology foundation/American heart association task force on practice guidelines (Journal of the American College of Cardiology (2011) 57 (1920-1959))

TY - JOUR

T1 - Erratum

T2 - 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (Updating the 2007 Guideline): A report of the American college of cardiology foundation/American heart association task force on practice guidelines (Journal of the American College of Cardiology (2011) 57 (1920-1959))

AU - Wright, R. Scott

AU - Anderson, Jeffrey L.

AU - Adams, Cynthia D.

AU - Bridges, Charles R.

AU - Casey, Donald E.

AU - Ettinger, Steven M.

AU - Fesmire, Francis M.

AU - Ganiats, Theodore G.

AU - Jneid, Hani

AU - Lincoff, A. Michael

AU - Peterson, Eric D.

AU - Philippides, George J.

AU - Theroux, Pierre

AU - Wenger, Nanette K.

AU - Zidar, James Patrick

N1 - Funding Information: The Task Force makes every effort to avoid actual, potential, or perceived conflicts of interest that may arise as a result of relationships with industry and other entities (RWI) among the writing group. Specifically, all members of the writing group, as well as peer reviewers of the document, are asked to disclose all current relationships and those existing 12 months before initiation of the writing effort. In response to implementation of a newly revised RWI policy approved by the ACC and AHA, it is also required that the writing group chair plus a majority of the writing group (50%) have no relevant RWI. All guideline recommendations require a confidential vote by the writing group and must be approved by a consensus of the members voting. Members who were recused from voting are noted on the title page of this document and in Appendix 1 . Members must recuse themselves from voting on any recommendation to which their RWI apply. Any writing group member who develops a new RWI during his or her tenure is required to notify guideline staff in writing. These statements are reviewed by the Task Force and all members during each conference call and/or meeting of the writing group and are updated as changes occur. For detailed information about guideline policies and procedures, please refer to the ACCF/AHA methodology and policies manual ( 1 ). Authors' and peer reviewers' RWI pertinent to this guideline are disclosed in Appendixes 1 and 2 , respectively. Additionally, to ensure complete transparency, writing group members' comprehensive disclosure information —including RWI not pertinent to this document—is available online as a supplement to this document. Disclosure information for the Task Force is also available online at www.cardiosource.org/ACC/About-ACC/Leadership/Guidelines-and-Documents-Task-Forces.aspx . The work of the writing group was supported exclusively by the ACCF and AHA without commercial support. Writing group members volunteered their time for this effort.

PY - 2011/5/10

Y1 - 2011/5/10

KW - ACCF/AHA Practice Guidelines

KW - antiplatelet therapy

KW - focused update

KW - glycoprotein IIb/IIIa inhibitors

KW - myocardial infarction

KW - nonST elevation

KW - percutaneous coronary intervention

KW - thienopyridines

KW - unstable angina

UR - http://www.scopus.com/inward/record.url?scp=79955622292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955622292&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2011.04.002

DO - 10.1016/j.jacc.2011.04.002

M3 - Comment/debate

AN - SCOPUS:79955622292

VL - 57

SP - 1960

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 19

ER -